We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$998M
AUM Growth
+$120M
Cap. Flow
+$37.6M
Cap. Flow %
3.76%
Top 10 Hldgs %
30.51%
Holding
114
New
5
Increased
36
Reduced
8
Closed
5

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$11M
2
F icon
Ford
F
+$8.24M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$7.18M
4
EQR icon
Equity Residential
EQR
+$6.22M
5
EPD icon
Enterprise Products Partners
EPD
+$5.17M

Top Sells

Rank Stock Value
1
GIS icon
General Mills
GIS
+$9.38M
2
CAT icon
Caterpillar
CAT
+$8.76M
3
PRU icon
Prudential Financial
PRU
+$8.66M
4
MET icon
MetLife
MET
+$7.74M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.39M

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.07%
2 Technology 13.88%
3 Financials 10.31%
4 Industrials 8.21%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$140B
$17.2M 1.72%
535,105
– –
MMP
27
DELISTED
Magellan Midstream Partners, L.P.
MMP
$16.4M 1.64%
231,800
+100,600
+77% +$7.18M
MXIM
28
DELISTED
Maxim Integrated Products
MXIM
$16.4M 1.64%
410,100
+94,900
+30% +$3.74M
CVX icon
29
Chevron
CVX
$388B
$16M 1.6%
155,450
+7,800
+5% +$796K
KMB icon
30
Kimberly-Clark
KMB
$36.4B
$15.9M 1.59%
125,800
– –
DRI icon
31
Darden Restaurants
DRI
$22.5B
$15.3M 1.53%
249,100
+39,600
+19% +$2.46M
CME icon
32
CME Group
CME
$92.2B
$15.1M 1.51%
144,000
+12,800
+10% +$1.34M
XOM icon
33
ExxonMobil
XOM
$651B
$15M 1.5%
171,456
+16,500
+11% +$1.46M
WM icon
34
Waste Management
WM
$95.9B
$14.4M 1.44%
225,800
– –
TGT icon
35
Target
TGT
$62.1B
$13.9M 1.39%
202,200
+31,200
+18% +$2.24M
BOH icon
36
Bank of Hawaii
BOH
$3.33B
$13.3M 1.34%
183,800
+40,900
+29% +$2.87M
MCHP icon
37
Microchip Technology
MCHP
$42.8B
$13M 1.3%
417,800
– –
LYB icon
38
LyondellBasell Industries
LYB
$19.5B
$11.6M 1.16%
144,100
+32,300
+29% +$2.5M
WR
39
DELISTED
Westar Energy Inc
WR
$10.9M 1.09%
192,100
– –
AEE icon
40
Ameren
AEE
$31.5B
$10.7M 1.07%
217,500
+20,600
+10% +$1.05M
MAT icon
41
Mattel
MAT
$4.17B
$10.5M 1.06%
348,300
+2,200
+0.6% +$71.9K
PG icon
42
Procter & Gamble
PG
$343B
$10.2M 1.02%
113,800
– –
WMT icon
43
Walmart Inc
WMT
$871B
$10.2M 1.02%
424,560
+45,900
+12% +$1.11M
TEVA icon
44
Teva Pharmaceuticals
TEVA
$35.9B
$9.74M 0.98%
+211,600
New +$11M
BA icon
45
Boeing
BA
$165B
$9.66M 0.97%
73,300
+7,900
+12% +$1.04M
PM icon
46
Philip Morris
PM
$301B
$9.63M 0.96%
99,000
-52,700
-35% -$5.28M
EMR icon
47
Emerson Electric
EMR
$82.9B
$9.54M 0.96%
175,100
+6,600
+4% +$354K
ED icon
48
Consolidated Edison
ED
$41.6B
$9.41M 0.94%
125,000
+13,700
+12% +$1.06M
IVZ icon
49
Invesco
IVZ
$13.3B
$9.38M 0.94%
300,000
-62,200
-17% -$1.83M
DD icon
50
DuPont de Nemours
DD
$18.6B
$9.31M 0.93%
70,921
– –
1
2
3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2016 Portfolio in Review

As of Q3 2016, Payden & Rygel held 114 positions worth $998M, up 14% from $878M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Payden & Rygel deployed $37.6M of net new capital in Q3 2016, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was Teva Pharmaceuticals: 211,600 shares worth $9.74M.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was General Mills, an estimated $9.38M trimmed.

  • Payden & Rygel's largest Q3 2016 buy was Teva Pharmaceuticals: 211,600 shares worth $9.74M.
  • Payden & Rygel added most to Magellan Midstream Partners, L.P. in Q3 2016, an estimated $7.18M increase.
  • Payden & Rygel's biggest Q3 2016 reduction was General Mills, cutting an estimated $9.38M.
  • Payden & Rygel fully exited Caterpillar in Q3 2016, selling an estimated $8.76M.
  • Payden & Rygel's ten largest holdings make up 31% of its $998M portfolio in Q3 2016.
  • Payden & Rygel opened 5 new positions and closed 5 in Q3 2016.
  • Payden & Rygel's portfolio value rose 14% quarter-over-quarter to $998M.

Based on Payden & Rygel's 13F filing for Q3 2016, filed 9 Nov 2016.